Heppenstall Richard reported grant involving 89,286 shares of CARLSMED, INC. at $0.00 for $0 on Sep 28, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
CFO, Treasurer
CFO, Treasurer
Filed Sep 30, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
89,286Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
89,286Direct
Trade date
Sep 28, 2026Grant
Filed
Sep 30, 2026, 7:37 PM ET2-day reporting delay
Accession
0001193125-26-409437Code A · Transaction 232221
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 28, 2026Grant180,137$0.00$0Trade 232222
2 transaction rows in this filing. Joint filers share the same rows.

CARL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CARL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago +11%1d ago +7.3%
Returns since7d +2.2%30d +6.3%90d180d1y

Footnotes in full

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock . The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date, September 28, 2026, subject to the Reporting Person's continued service through each such vesting date. F2: Includes 180,137 unvested stock options exercisable into approximately 180,137 shares of the Issuer's Common Stock. 25% of the stock options will vest upon the one year anniversary of the grant date, September 28, 2026, and the remaining 75% of the stock options will vest in 1/12th installments on a quarterly basis thereafter, subject to the Reporting Person's continued service through each such vesting date.